Skip to Content
Merck
  • [Clinical, laboratory, and functional characteristic of patients with bronchial asthma and chronic obstructive pulmonary disease with disturbances of oxalic acid metabolism].

[Clinical, laboratory, and functional characteristic of patients with bronchial asthma and chronic obstructive pulmonary disease with disturbances of oxalic acid metabolism].

Klinicheskaia meditsina (2013-06-26)
L O Shaĭlieva, G B Fedoseev, M L Zorina, M A Petrova, V I Trofimov, A P Kakliugin
ABSTRACT

We studied the role of oxalate release through the airways as a potential injurious factor in the development of inflammation, bronchial obstruction and cough syndrome (respiratory oxalosis). Detection of oxalates in bronhcoalveolar lavage fluid and daily urine is the most valuable method for diagnostics of oxalates. Systemic effects, such as cholelithiasis, urolithiasis, and spinal osteochondrosis are characteristic clinical signs of respiratory oxalosis, besides purely respiratory symptoms.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Oxalic acid, purified grade, 99.999% trace metals basis
Supelco
Oxalic acid concentrate, 0.1 M (COOH)2 (0.2N), eluent concentrate for IC
Sigma-Aldrich
Oxalic acid, 98%
Sigma-Aldrich
Oxalic acid, ReagentPlus®, ≥99%
Sigma-Aldrich
Oxalic acid, puriss. p.a., anhydrous, ≥99.0% (RT)
Supelco
Sodium oxalate, reference material for titrimetry, certified by BAM, >99.5%
Sigma-Aldrich
Sodium oxalate, ≥99.99% trace metals basis
Sigma-Aldrich
Sodium oxalate, BioXtra
Sigma-Aldrich
Sodium oxalate, puriss. p.a., ACS reagent, ≥99.5% (RT)
Sigma-Aldrich
Sodium oxalate, ACS reagent, ≥99.5%